Chemical Structure (Image 01)
Bendamustine Hydrochloride Injection
Product Images NDC 10019-079
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Bendamustine Hydrochloride (NDC 10019-079). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Baxter Healthcare Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Image 02)
Representative Vial Label Pane 1 Of 3 (Image 03)
This is a description of Bendamustine HCl Injection, which is a medication administered by intravenous infusion. The medication comes in a multiple-dose vial containing 100 mg/4 mL of solution (25 mg/mL). Before administration, the required dose needs to be diluted in a 500 mL admixture. The vial should be stored in the refrigerator (2-8°C) and protected from light. The manufacturer is Baxter Healthcare Corp. and the product is from Germany. Dosage information can be found in the Prescribing Information.*
Representative Vial Label Panel 2 Of 3 (Image 04)
This text provides instructions on how to transfer a required dose of a medication with a concentration of 25 mg/mL into a 500mL infusion bag of either 0.9% Sodium Chloride Injection or 2.5% Dextrose/0.45% Sodium Chloride Injection. The text emphasizes the importance of not using the medication if any solid or particulate matter is observed.*
Representative Vial Label Panel 3 Of 3 (Image 05)
Bendamustine HCl Injection is a concentrate solution with a strength of 25 mg/mL and comes in a 100 mg/4 mL vial. However, it is necessary to dilute the solution before administering it. The prescribing information contains instructions for dilution. Users are advised to exercise caution when handling the concentrate solution.*
Representative Carton Lbl (Image 06)
This is a medication label for Bendamustine HCI Injection used for intravenous infusion only. Dosage, storage and dilution instructions are given along with product information. The medication is available in a 100mg/4mL exchange containing 25mg/mL Bendamustine HCI. The label also provides the NDC codes and cautions to protect from light.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
